Therapeutic transcatheter arterial embolization in the management of intractable haemorrhage from pelvic urological malignancies: preliminary experience and long-term follow-up

2003 ◽  
Vol 92 (3) ◽  
pp. 245-247 ◽  
Author(s):  
G. Nabi ◽  
N. Sheikh ◽  
D. Greene ◽  
R. Marsh
1997 ◽  
Vol 37 (1) ◽  
pp. 71
Author(s):  
Young Hwan Lee ◽  
Young Min Han ◽  
Chong Soo Kim ◽  
Gyung Ho Chung ◽  
Sang Yong Lee ◽  
...  

2010 ◽  
Vol 105 (3) ◽  
pp. 390-394 ◽  
Author(s):  
Christopher M. Chick ◽  
Bien-Soo Tan ◽  
Christopher Cheng ◽  
Manish Taneja ◽  
Richard Lo ◽  
...  

2007 ◽  
Vol 7 ◽  
pp. 1567-1574 ◽  
Author(s):  
Ahmed El-Assmy ◽  
Tarek Mohsen

The purpose of this study was to evaluate the efficacy and long-term complications of internal iliac artery embolization as a palliative measure in the control of intractable hemorrhage from advanced bladder malignancy. From January 1998 through December 2005, seven patients underwent transcatheter arterial embolization (TAE) of anterior division of internal iliac artery bilaterally for intractable bladder hemorrhage. After embolization, patients were followed for the efficacy of the procedure in controlling hematuria and complications. TAE was successful in immediate control of severe hemorrhage in all seven patients after a mean period of 4 days. At a mean (range) follow-up of 10 (6–12) months, the hemorrhage was permanently controlled in four (57%) patients. Three patients developed hematuria and required emergency admissions; two had mild hematuria and were managed conservatively, and the remaining one required a second attempt of embolization after 2 months from the first one. During the whole period of follow-up, there were no significant complications related to embolization. Internal iliac artery embolization is an effective and minimally invasive option when managing advanced bladder malignancies presenting with intractable bleeding. The long-term follow-up showed control of bleeding in the majority of such patients with no serious complications.


Cancer ◽  
2002 ◽  
Vol 95 (6) ◽  
pp. 1317-1325 ◽  
Author(s):  
Patrick P. Lin ◽  
Volkan B. Guzel ◽  
Marcio F. Moura ◽  
Sidney Wallace ◽  
Robert S. Benjamin ◽  
...  

2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.


Sign in / Sign up

Export Citation Format

Share Document